Interagency Coordinating Committee on the Validation of Alternative Methods; Notice of Public Meeting; Request for Public Input, 20001-20003 [2015-08528]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices
asabaliauskas on DSK5VPTVN1PROD with NOTICES
quarter to the Payment Management
Services, HHS at: https://
www.dpm.psc.gov. It is recommended
that the applicant also send a copy of
the FFR (SF–425) report to the Grants
Management Specialist. Failure to
submit timely reports may cause a
disruption in timely payments to the
organization.
Grantees are responsible and
accountable for accurate information
being reported on all required reports:
the Progress Reports and Federal
Financial Report.
C. Federal Subaward Reporting System
(FSRS)
This award may be subject to the
Transparency Act subaward and
executive compensation reporting
requirements of 2 CFR part 170.
The Transparency Act requires the
OMB to establish a single searchable
database, accessible to the public, with
information on financial assistance
awards made by Federal agencies. The
Transparency Act also includes a
requirement for recipients of Federal
grants to report information about firsttier subawards and executive
compensation under Federal assistance
awards.
IHS has implemented a Term of
Award into all IHS Standard Terms and
Conditions, NoAs and funding
announcements regarding the FSRS
reporting requirement. This IHS Term of
Award is applicable to all IHS grant and
cooperative agreements issued on or
after October 1, 2010, with a $25,000
subaward obligation dollar threshold
met for any specific reporting period.
Additionally, all new (discretionary)
IHS awards (where the project period is
made up of more than one budget
period) and where: (1) The project
period start date was October 1, 2010 or
after and (2) the primary awardee will
have a $25,000 subaward obligation
dollar threshold during any specific
reporting period will be required to
address the FSRS reporting. For the full
IHS award term implementing this
requirement and additional award
applicability information, visit the DGM
Grants Policy Web site at: https://
www.ihs.gov/dgm/
index.cfm?module=dsp_dgm_policy_
topics.
Telecommunication for the hearing
impaired is available at: TTY (301) 443–
6394.
VII. Agency Contacts
1. Questions on the programmatic
issues may be directed to:
Ms. Nancy Bill, Program Manager,
Injury Prevention Program, IHS, 801
Thompson Ave, TMP Suite 610,
VerDate Sep<11>2014
17:42 Apr 13, 2015
Jkt 235001
Rockville, MD 20852, Phone: (301)
443–0105, Fax: (301) 443–7538, EMail: Nancy.Bill@ihs.gov
2. Questions on grants management
and fiscal matters may be directed to:
Pallop Chareonvootitam, Senior Grant
Management Specialist, 801
Thompson Avenue, TMP Suite 360–
78, Rockville, MD 20852, Phone: (301)
443–2195; or the DGM main line (301)
443–5204, Fax: (301) 443–9602, EMail: Pallop.Chareonvootitam@
ihs.gov.
3. Questions on systems matters may
be directed to:
Paul Gettys, Grant Systems Coordinator,
801 Thompson Avenue, TMP Suite
360, Rockville, MD 20852, Phone:
(301) 443–2114; or the DGM main line
(301) 443–5204, Fax: (301) 443–9602,
E-Mail: Paul.Gettys@ihs.gov.
VIII. Other Information
The Public Health Service strongly
encourages all cooperative agreement
and contract recipients to provide a
smoke-free workplace and promote the
non-use of all tobacco products. In
addition, Public Law 103–227, the ProChildren Act of 1994, prohibits smoking
in certain facilities (or in some cases,
any portion of the facility) in which
regular or routine education, library,
day care, health care, or early childhood
development services are provided to
children. This is consistent with the
HHS mission to protect and advance the
physical and mental health of the
American people.
Dated: April 3, 2015,
Robert G. McSwain,
Acting Director, Indian Health Service.
20001
Name of Committee: Center for Scientific
Review Advisory Council.
Date: May 18, 2015.
Time: 8:30 a.m. to 3:00 p.m.
Agenda: Provide advice to the Director,
Center for Scientific Review (CSR), on
matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 3091, Bethesda, MD
20892.
Contact Person: Rene Etcheberrigaray, MD.
Deputy Director, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 3030, MSC 7776,
Bethesda, MD 20892, (301) 435–1111,
etcheber@csr.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
into NIH buildings. Visitors will be asked to
show one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the purpose
of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
public.csr.nih.gov/aboutcsr/
CSROrganization/Pages/CSRAC.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2015–08605 Filed 4–13–15; 8:45 am]
Dated: April 8, 2015.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4165–16–P
[FR Doc. 2015–08459 Filed 4–13–15; 8:45 am]
BILLING CODE 4140–01P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Center
for Scientific Review Advisory Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee
on the Validation of Alternative
Methods; Notice of Public Meeting;
Request for Public Input
The Interagency Coordinating
Committee on the Validation of
Alternative Methods (ICCVAM) will
hold a public forum to share
information and facilitate direct
communication of ideas and suggestions
from stakeholders. Interested persons
may attend in person or remotely. Time
will be set aside for public statements
and questions on the topics discussed.
SUMMARY:
E:\FR\FM\14APN1.SGM
14APN1
asabaliauskas on DSK5VPTVN1PROD with NOTICES
20002
Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices
Registration is requested for both public
attendance and oral statements, and
required for remote access. Information
about the meeting and registration is
available at https://ntp.niehs.nih.gov/go/
iccvamforum-2015.
DATES: Meeting: May 27, 2015, 9:00 a.m.
to approximately 12:00 p.m. Eastern
Daylight Time (EDT).
Registration for Onsite Meeting:
Deadline is May 15, 2015.
Registration for Webcast: Deadline is
May 27, 2015
Submission of Oral Public Statements:
Deadline is May 15, 2015.
ADDRESSES:
Meeting Location: William H. Natcher
Conference Center, National Institutes of
Health, Bethesda, MD 20892.
Meeting Web page: The preliminary
agenda, registration, and other meeting
materials are at https://ntp.niehs.nih.gov/
go/iccvamforum-2015.
FOR FURTHER INFORMATION CONTACT: Dr.
Warren S. Casey, Director, National
Toxicology Program Interagency Center
for the Evaluation of Alternative
Toxicological Methods (NICEATM);
email: warren.casey@nih.gov; telephone:
(919) 316–4729.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM promotes the
development and validation of chemical
safety testing methods that protect
human health and the environment
while replacing, reducing, or refining
animal use.
ICCVAM’s goals include promotion of
national and international partnerships
between governmental and
nongovernmental groups, including
academia, industry, advocacy groups,
and other key stakeholders. To foster
these partnerships ICCVAM initiated
annual public forums in 2014 to share
information and facilitate direct
communication of ideas and suggestions
from stakeholders (79 FR 25136).
The second of these forums will be
held on May 27, 2015, at the National
Institutes of Health (NIH) in Bethesda,
MD. The meeting will begin with
presentations by NICEATM and
ICCVAM members on current activities
related to the development and
validation of alternative test methods
and approaches for assessing acute
systemic toxicity, endocrine activity,
vaccine safety, and skin sensitization
potential, as well as updates on
ICCVAM processes. Following each
presentation, there will be an
opportunity for participants to ask
questions of the ICCVAM members.
Instructions for submitting questions
will be provided to remote participants
prior to the webcast. The agenda also
includes time for participants to make
VerDate Sep<11>2014
17:42 Apr 13, 2015
Jkt 235001
public oral statements to inform
ICCVAM on topics relevant to its
mission and current activities.
Preliminary Agenda and Other
Meeting Information: The preliminary
agenda, ICCVAM roster and other
background materials, and public
statements submitted prior to the
meeting will be posted at https://
ntp.niehs.nih.gov/go/iccvamforum-2015
to allow remote participation. Public
statements will be distributed to
NICEATM and ICCVAM members.
Interested individuals are encouraged to
visit this Web page to stay abreast of the
most current meeting information.
Meeting and Registration: This
meeting is open to the public with time
scheduled for oral public statements
and for questions following ICCVAM’s
and NICEATM’s presentations. The
public may attend the meeting at NIH,
where attendance is limited only by the
space available, or view remotely by
webcast. Those planning to attend the
meeting in person are encouraged to
register at https://ntp.niehs.nih.gov/go/
iccvamforum-2015 by May 15, 2015, to
facilitate planning for appropriate
meeting space. Those planning to view
the webcast must register at https://
ntp.niehs.nih.gov/go/iccvamforum-2015
by May 27, 2015. The URL for the
webcast will be provided in the email
confirming registration.
Visitor and security information for
visitors to NIH is available at https://
www.nih.gov/about/visitor/index.htm.
Individuals with disabilities who need
accommodation to participate in this
event should contact Dr. Elizabeth
Maull at phone: (919) 316–4668 or
email: maull@niehs.nih.gov. TTY users
should contact the Federal TTY Relay
Service at 800–877–8339. Requests
should be made at least five business
days in advance of the event.
Request for Oral Public Statements:
Time will be allotted during the meeting
for oral public statements with
associated slides relevant to ICCVAM’s
mission and current activities. The
number and length of presentations may
be limited based on available time.
Submitters will be identified by their
name and affiliation and/or sponsoring
organization, if applicable. Persons
submitting public statements and/or
associated slides should include their
name, affiliation (if any), mailing
address, telephone, email, and
sponsoring organization (if any) with
the document.
Persons wishing to present oral
statements are encouraged to indicate
the topic(s) on which they plan to speak
on the registration form. They should
also provide a copy of their statement to
Dr. Elizabeth Maull at email: maull@
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
niehs.nih.gov by May 15, 2015, to allow
time for review by NICEATM and
ICCVAM and posting to the meeting
page prior to the forum. Written
statements may supplement and expand
the oral presentation.
Registration for oral public statements
will be available onsite, although onsite
registration and time allotted for these
statements may be limited based on the
number of individuals who register to
make statements and available time. If
registering onsite and reading from
written text, please bring 20 copies of
the statement for distribution and to
supplement the record.
In addition to in-person oral
statements at the meeting, public
statements may be presented by
teleconference line. Directions for
accessing the meeting by teleconference
line will be provided to registered
participants prior to the meeting date.
Responses to this notice are
voluntary. No proprietary, classified,
confidential, or sensitive information
should be included in statements
submitted in response to this notice or
presented during the meeting. This
request for input is for planning
purposes only and is not a solicitation
for applications or an obligation on the
part of the U.S. Government to provide
support for any ideas identified in
response to the request. Please note that
the U.S. Government will not pay for
the preparation of any information
submitted or for its use of that
information.
Background Information on ICCVAM
and NICEATM: ICCVAM is an
interagency committee composed of
representatives from 15 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
and integrated testing strategies with
regulatory applicability and promotes
the scientific validation and regulatory
acceptance of testing methods that both
more accurately assess the safety and
hazards of chemicals and products and
replace, reduce, or refine (enhance
animal well-being and minimize or
prevent pain and distress) animal use.
The ICCVAM Authorization Act of 2000
(42 U.S.C. 285l–3) establishes ICCVAM
as a permanent interagency committee
of the NIEHS and provides the authority
for ICCVAM involvement in activities
relevant to the development of
alternative test methods. ICCVAM acts
to ensure that new and revised test
methods are validated to meet the needs
of Federal agencies, increase the
efficiency and effectiveness of federal
E:\FR\FM\14APN1.SGM
14APN1
Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices
agency test method review, and
optimize utilization of scientific
expertise outside the federal
Government. Additional information
about ICCVAM can be found at https://
ntp.niehs.nih.gov/go/iccvam.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,
and conducts and publishes analyses
and evaluations of data from new,
revised, and alternative testing
approaches. NICEATM and ICCVAM
work collaboratively to evaluate new
and improved testing approaches
applicable to the needs of U.S. federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative testing
approaches for validation studies and
technical evaluations. Additional
information about NICEATM can be
found at https://ntp.niehs.nih.gov/go/
niceatm.
Dated: April 6, 2015.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2015–08528 Filed 4–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
[Docket No. TSA–2002–11602]
Intent To Request Renewal From OMB
of One Current Public Collection of
Information: Security Programs for
Foreign Air Carriers
Transportation Security
Administration, DHS.
ACTION: 60-Day notice.
AGENCY:
The Transportation Security
Administration (TSA) invites public
comment on one currently approved
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0005,
abstracted below that we will submit to
OMB for renewal in compliance with
the Paperwork Reduction Act (PRA).
The ICR describes the nature of the
information collection and its expected
burden. This information collection is
mandatory for foreign air carriers and
must be submitted prior to entry into
the United States.
DATES: Send your comments by June 15,
2015.
ADDRESSES: Comments may be emailed
to TSAPRA@tsa.dhs.gov or delivered to
the TSA PRA Officer, Office of
Information Technology (OIT), TSA–11,
asabaliauskas on DSK5VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:42 Apr 13, 2015
Jkt 235001
Transportation Security Administration,
601 South 12th Street, Arlington, VA
20598–6011.
FOR FURTHER INFORMATION CONTACT:
Christina A. Walsh at the above address,
or by telephone (571) 227–2062.
SUPPLEMENTARY INFORMATION:
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation is
available at https://www.reginfo.gov.
Therefore, in preparation for OMB
review and approval of the following
information collection, TSA is soliciting
comments to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Information Collection Requirement
OMB Control Number 1652–0005;
Security Programs for Foreign Air
Carriers, 49 CFR part 1546. TSA uses
the information collected to determine
compliance with 49 CFR part 1546 and
to ensure passenger safety by
monitoring foreign air carrier security
procedures. Foreign air carriers must
carry out security measures to provide
for the safety of persons and property
traveling on flights provided by the
foreign air carrier against acts of
criminal violence and air piracy, and
the introduction of explosives,
incendiaries, or weapons aboard an
aircraft. This information collection is
mandatory for foreign air carriers and
must be submitted prior to entry into
the United States. The information TSA
collects includes identifying
information on foreign air carriers’ flight
crews and passengers. Specifically, TSA
requires foreign air carriers to submit
the following information: (1) A master
crew list of all flight and cabin crew
members flying to and from the United
States; (2) the flight crew list on a flightby-flight basis; and (3) passenger
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
20003
information on a flight-by-flight basis.
Foreign air carriers are required to
provide this information via electronic
means. On June 19, 2014, TSA removed
the previous security program
requirement that foreign air carriers
submit information regarding the
amount of cargo screened because all
foreign air carriers are required to screen
100% of cargo.
Additionally, foreign air carriers must
maintain these records, as well as
training records for crew members and
individuals performing security-related
functions, and make them available to
TSA for inspection upon request. TSA
will continue to collect information to
determine foreign air carrier compliance
with other requirements of 49 CFR part
1546. TSA estimates that there will be
approximately 170 respondents to the
information collection, with an annual
burden estimate of 1,029,010 hours.
Dated: April 6, 2015.
Christina A. Walsh,
TSA Paperwork Reduction Act Officer, Office
of Information Technology.
[FR Doc. 2015–08562 Filed 4–13–15; 8:45 am]
BILLING CODE 9110–05P
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Extension of Agency Information
Collection Activity Under OMB Review:
TSA Office of Training and Workforce
Engagement Canine Training and
Evaluation Branch End of Course
Level 1 Evaluation (Formerly Named:
National Explosives Detection Canine
Team Program Handler Training
Assessment Survey)
Transportation Security
Administration, DHS.
ACTION: 30-day notice.
AGENCY:
This notice announces that
the Transportation Security
Administration (TSA) has forwarded the
Information Collection Request (ICR),
Office of Management and Budget
(OMB) control number 1652–0041
abstracted below, to OMB for review
and approval of an extension of the
currently-approved collection under the
Paperwork Reduction Act (PRA). The
ICR describes the nature of the
information collection and its expected
burden. TSA published a Federal
Register notice, with a 60-day comment
period, describing the collection of
information on December 29, 2014, 79
FR 78099. The collection involves the
submission of numerical ratings and
written comments about the quality of
SUMMARY:
E:\FR\FM\14APN1.SGM
14APN1
]]>Agencies
[Federal Register Volume 80, Number 71 (Tuesday, April 14, 2015)]
[Notices]
[Pages 20001-20003]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08528]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Interagency Coordinating Committee on the Validation of
Alternative Methods; Notice of Public Meeting; Request for Public Input
SUMMARY: The Interagency Coordinating Committee on the Validation of
Alternative Methods (ICCVAM) will hold a public forum to share
information and facilitate direct communication of ideas and
suggestions from stakeholders. Interested persons may attend in person
or remotely. Time will be set aside for public statements and questions
on the topics discussed.
[[Page 20002]]
Registration is requested for both public attendance and oral
statements, and required for remote access. Information about the
meeting and registration is available at https://ntp.niehs.nih.gov/go/iccvamforum-2015.
DATES: Meeting: May 27, 2015, 9:00 a.m. to approximately 12:00 p.m.
Eastern Daylight Time (EDT).
Registration for Onsite Meeting: Deadline is May 15, 2015.
Registration for Webcast: Deadline is May 27, 2015
Submission of Oral Public Statements: Deadline is May 15, 2015.
ADDRESSES:
Meeting Location: William H. Natcher Conference Center, National
Institutes of Health, Bethesda, MD 20892.
Meeting Web page: The preliminary agenda, registration, and other
meeting materials are at https://ntp.niehs.nih.gov/go/iccvamforum-2015.
FOR FURTHER INFORMATION CONTACT: Dr. Warren S. Casey, Director,
National Toxicology Program Interagency Center for the Evaluation of
Alternative Toxicological Methods (NICEATM); email:
warren.casey@nih.gov; telephone: (919) 316-4729.
SUPPLEMENTARY INFORMATION:
Background: ICCVAM promotes the development and validation of
chemical safety testing methods that protect human health and the
environment while replacing, reducing, or refining animal use.
ICCVAM's goals include promotion of national and international
partnerships between governmental and nongovernmental groups, including
academia, industry, advocacy groups, and other key stakeholders. To
foster these partnerships ICCVAM initiated annual public forums in 2014
to share information and facilitate direct communication of ideas and
suggestions from stakeholders (79 FR 25136).
The second of these forums will be held on May 27, 2015, at the
National Institutes of Health (NIH) in Bethesda, MD. The meeting will
begin with presentations by NICEATM and ICCVAM members on current
activities related to the development and validation of alternative
test methods and approaches for assessing acute systemic toxicity,
endocrine activity, vaccine safety, and skin sensitization potential,
as well as updates on ICCVAM processes. Following each presentation,
there will be an opportunity for participants to ask questions of the
ICCVAM members. Instructions for submitting questions will be provided
to remote participants prior to the webcast. The agenda also includes
time for participants to make public oral statements to inform ICCVAM
on topics relevant to its mission and current activities.
Preliminary Agenda and Other Meeting Information: The preliminary
agenda, ICCVAM roster and other background materials, and public
statements submitted prior to the meeting will be posted at https://ntp.niehs.nih.gov/go/iccvamforum-2015 to allow remote participation.
Public statements will be distributed to NICEATM and ICCVAM members.
Interested individuals are encouraged to visit this Web page to stay
abreast of the most current meeting information.
Meeting and Registration: This meeting is open to the public with
time scheduled for oral public statements and for questions following
ICCVAM's and NICEATM's presentations. The public may attend the meeting
at NIH, where attendance is limited only by the space available, or
view remotely by webcast. Those planning to attend the meeting in
person are encouraged to register at https://ntp.niehs.nih.gov/go/iccvamforum-2015 by May 15, 2015, to facilitate planning for
appropriate meeting space. Those planning to view the webcast must
register at https://ntp.niehs.nih.gov/go/iccvamforum-2015 by May 27,
2015. The URL for the webcast will be provided in the email confirming
registration.
Visitor and security information for visitors to NIH is available
at https://www.nih.gov/about/visitor/index.htm. Individuals with
disabilities who need accommodation to participate in this event should
contact Dr. Elizabeth Maull at phone: (919) 316-4668 or email:
maull@niehs.nih.gov. TTY users should contact the Federal TTY Relay
Service at 800-877-8339. Requests should be made at least five business
days in advance of the event.
Request for Oral Public Statements: Time will be allotted during
the meeting for oral public statements with associated slides relevant
to ICCVAM's mission and current activities. The number and length of
presentations may be limited based on available time. Submitters will
be identified by their name and affiliation and/or sponsoring
organization, if applicable. Persons submitting public statements and/
or associated slides should include their name, affiliation (if any),
mailing address, telephone, email, and sponsoring organization (if any)
with the document.
Persons wishing to present oral statements are encouraged to
indicate the topic(s) on which they plan to speak on the registration
form. They should also provide a copy of their statement to Dr.
Elizabeth Maull at email: maull@niehs.nih.gov by May 15, 2015, to allow
time for review by NICEATM and ICCVAM and posting to the meeting page
prior to the forum. Written statements may supplement and expand the
oral presentation.
Registration for oral public statements will be available onsite,
although onsite registration and time allotted for these statements may
be limited based on the number of individuals who register to make
statements and available time. If registering onsite and reading from
written text, please bring 20 copies of the statement for distribution
and to supplement the record.
In addition to in-person oral statements at the meeting, public
statements may be presented by teleconference line. Directions for
accessing the meeting by teleconference line will be provided to
registered participants prior to the meeting date.
Responses to this notice are voluntary. No proprietary, classified,
confidential, or sensitive information should be included in statements
submitted in response to this notice or presented during the meeting.
This request for input is for planning purposes only and is not a
solicitation for applications or an obligation on the part of the U.S.
Government to provide support for any ideas identified in response to
the request. Please note that the U.S. Government will not pay for the
preparation of any information submitted or for its use of that
information.
Background Information on ICCVAM and NICEATM: ICCVAM is an
interagency committee composed of representatives from 15 federal
regulatory and research agencies that require, use, generate, or
disseminate toxicological and safety testing information. ICCVAM
conducts technical evaluations of new, revised, and alternative safety
testing methods and integrated testing strategies with regulatory
applicability and promotes the scientific validation and regulatory
acceptance of testing methods that both more accurately assess the
safety and hazards of chemicals and products and replace, reduce, or
refine (enhance animal well-being and minimize or prevent pain and
distress) animal use. The ICCVAM Authorization Act of 2000 (42 U.S.C.
285l-3) establishes ICCVAM as a permanent interagency committee of the
NIEHS and provides the authority for ICCVAM involvement in activities
relevant to the development of alternative test methods. ICCVAM acts to
ensure that new and revised test methods are validated to meet the
needs of Federal agencies, increase the efficiency and effectiveness of
federal
[[Page 20003]]
agency test method review, and optimize utilization of scientific
expertise outside the federal Government. Additional information about
ICCVAM can be found at https://ntp.niehs.nih.gov/go/iccvam.
NICEATM administers ICCVAM, provides scientific and operational
support for ICCVAM-related activities, and conducts and publishes
analyses and evaluations of data from new, revised, and alternative
testing approaches. NICEATM and ICCVAM work collaboratively to evaluate
new and improved testing approaches applicable to the needs of U.S.
federal agencies. NICEATM and ICCVAM welcome the public nomination of
new, revised, and alternative testing approaches for validation studies
and technical evaluations. Additional information about NICEATM can be
found at https://ntp.niehs.nih.gov/go/niceatm.
Dated: April 6, 2015.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2015-08528 Filed 4-13-15; 8:45 am]
BILLING CODE 4140-01-P
